Your browser doesn't support javascript.
loading
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer.
Davidson, T M; Lebreton, C L; Hendricksen, A E Wahner; Atkinson, H J; Larson, M C; Oberg, A L; Provencher, D M; Glaspy, J A; Karlan, B Y; Slamon, D J; Konecny, G E; Ray-Coquard, I L.
Afiliación
  • Davidson TM; Division of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Lebreton CL; Centre Léon Bérard, Lyon, France.
  • Hendricksen AEW; Division of Oncology, Mayo Clinic, Rochester, MN, USA.
  • Atkinson HJ; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Science, Mayo Clinic, Rochester, MN, USA.
  • Larson MC; Division of Clinical Trials and Biostatistics, Department of Quantitative Health Science, Mayo Clinic, Rochester, MN, USA.
  • Oberg AL; Division of Computational Biology, Department of Quantitative Health Science, Mayo Clinic, Rochester, MN, USA.
  • Provencher DM; CHUM - Pavillon Notre-Dame, Montréal, QC, Canada.
  • Glaspy JA; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Karlan BY; Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Slamon DJ; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Konecny GE; Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA; Division of Gynecologic Oncology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: gkonecny@mednet.ucla.edu.
  • Ray-Coquard IL; Centre Léon Bérard, Lyon, France; Health Services and Performance Research Lab (EA 7425 HESPER), University Claude Bernard Lyon 1, 69008 Lyon, France.
Gynecol Oncol ; 170: 221-228, 2023 03.
Article en En | MEDLINE | ID: mdl-36709663
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Anticuerpos Monoclonales Humanizados Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans Idioma: En Revista: Gynecol Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos